166 related articles for article (PubMed ID: 14663775)
1. Second cancers after breast cancer treatment.
Matesich SM; Shapiro CL
Semin Oncol; 2003 Dec; 30(6):740-8. PubMed ID: 14663775
[TBL] [Abstract][Full Text] [Related]
2. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
3. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study.
Chaplain G; Milan C; Sgro C; Carli PM; Bonithon-Kopp C
J Clin Oncol; 2000 Aug; 18(15):2836-42. PubMed ID: 10920131
[TBL] [Abstract][Full Text] [Related]
5. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
Diamandidou E; Buzdar AU; Smith TL; Frye D; Witjaksono M; Hortobagyi GN
J Clin Oncol; 1996 Oct; 14(10):2722-30. PubMed ID: 8874333
[TBL] [Abstract][Full Text] [Related]
6. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
7. Side effects of adjuvant treatment of breast cancer.
Shapiro CL; Recht A
N Engl J Med; 2001 Jun; 344(26):1997-2008. PubMed ID: 11430330
[No Abstract] [Full Text] [Related]
8. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy.
Woodward WA; Strom EA; McNeese MD; Perkins GH; Outlaw EL; Hortobagyi GN; Buzdar AU; Buchholz TA
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):327-35. PubMed ID: 12957242
[TBL] [Abstract][Full Text] [Related]
9. Cardiac effects of adjuvant therapy for early breast cancer.
Theodoulou M; Seidman AD
Semin Oncol; 2003 Dec; 30(6):730-9. PubMed ID: 14663774
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
11. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.
Berrington de Gonzalez A; Curtis RE; Gilbert E; Berg CD; Smith SA; Stovall M; Ron E
Br J Cancer; 2010 Jan; 102(1):220-6. PubMed ID: 19935795
[TBL] [Abstract][Full Text] [Related]
12. Treatment-associated leukemia following testicular cancer.
Travis LB; Andersson M; Gospodarowicz M; van Leeuwen FE; Bergfeldt K; Lynch CF; Curtis RE; Kohler BA; Wiklund T; Storm H; Holowaty E; Hall P; Pukkala E; Sleijfer DT; Clarke EA; Boice JD; Stovall M; Gilbert E
J Natl Cancer Inst; 2000 Jul; 92(14):1165-71. PubMed ID: 10904090
[TBL] [Abstract][Full Text] [Related]
13. Late effects of adjuvant therapy for breast cancer.
Shapiro CL; Recht A
J Natl Cancer Inst Monogr; 1994; (16):101-12. PubMed ID: 7999452
[No Abstract] [Full Text] [Related]
14. Breast-conserving therapy with adjuvant paclitaxel and radiation therapy: feasibility of concurrent treatment.
Ellerbroek N; Martino S; Mautner B; Tao ML; Rose C; Botnick L
Breast J; 2003; 9(2):74-8. PubMed ID: 12603378
[TBL] [Abstract][Full Text] [Related]
15. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma.
Zablotska LB; Neugut AI
Cancer; 2003 Mar; 97(6):1404-11. PubMed ID: 12627503
[TBL] [Abstract][Full Text] [Related]
16. Risks of second malignancies after breast cancer treatment: Long-term results.
Bazire L; De Rycke Y; Asselain B; Fourquet A; Kirova YM
Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
[TBL] [Abstract][Full Text] [Related]
17. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.
Fowble B; Hanlon A; Freedman G; Nicolaou N; Anderson P
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):679-90. PubMed ID: 11597809
[TBL] [Abstract][Full Text] [Related]
18. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.
Hooning MJ; Aleman BM; Hauptmann M; Baaijens MH; Klijn JG; Noyon R; Stovall M; van Leeuwen FE
J Clin Oncol; 2008 Dec; 26(34):5561-8. PubMed ID: 18854572
[TBL] [Abstract][Full Text] [Related]
19. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
20. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients.
Grantzau T; Overgaard J
Radiother Oncol; 2016 Dec; 121(3):402-413. PubMed ID: 27639892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]